CYP2C19 Polymorphism and PON-1 Activity in NSTE ACS: Vorapaxar Effect in Relation to Clopidogrel Metabolism in the TRACER Trial
Publication
, Journal Article
Tricoci, P; Chen, E; Neely, ML; Warner, A; Wong, PH; Sinnaeve, P; Wallentin, L; Jennings, LK; Storey, RF; Aylward, PE; White, HD; Held, C ...
Published in: CIRCULATION
November 26, 2013
Duke Scholars
Published In
CIRCULATION
EISSN
1524-4539
ISSN
0009-7322
Publication Date
November 26, 2013
Volume
128
Issue
22
Location
Dallas, TX
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Tricoci, P., Chen, E., Neely, M. L., Warner, A., Wong, P. H., Sinnaeve, P., … Moliterno, D. J. (2013). CYP2C19 Polymorphism and PON-1 Activity in NSTE ACS: Vorapaxar Effect in Relation to Clopidogrel Metabolism in the TRACER Trial. CIRCULATION, 128(22).
Tricoci, Pierluigi, Edmond Chen, Megan L. Neely, Amelia Warner, Peggy H. Wong, Peter Sinnaeve, Lars Wallentin, et al. “CYP2C19 Polymorphism and PON-1 Activity in NSTE ACS: Vorapaxar Effect in Relation to Clopidogrel Metabolism in the TRACER Trial.” CIRCULATION 128, no. 22 (November 26, 2013).
Tricoci P, Chen E, Neely ML, Warner A, Wong PH, Sinnaeve P, et al. CYP2C19 Polymorphism and PON-1 Activity in NSTE ACS: Vorapaxar Effect in Relation to Clopidogrel Metabolism in the TRACER Trial. CIRCULATION. 2013 Nov 26;128(22).
Tricoci, Pierluigi, et al. “CYP2C19 Polymorphism and PON-1 Activity in NSTE ACS: Vorapaxar Effect in Relation to Clopidogrel Metabolism in the TRACER Trial.” CIRCULATION, vol. 128, no. 22, LIPPINCOTT WILLIAMS & WILKINS, Nov. 2013.
Tricoci P, Chen E, Neely ML, Warner A, Wong PH, Sinnaeve P, Wallentin L, Jennings LK, Storey RF, Aylward PE, White HD, Van de Werf F, Armstrong PW, Held C, Valgimigli M, Harrington RA, Strony J, Mahaffey KW, Moliterno DJ. CYP2C19 Polymorphism and PON-1 Activity in NSTE ACS: Vorapaxar Effect in Relation to Clopidogrel Metabolism in the TRACER Trial. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2013 Nov 26;128(22).
Published In
CIRCULATION
EISSN
1524-4539
ISSN
0009-7322
Publication Date
November 26, 2013
Volume
128
Issue
22
Location
Dallas, TX
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology